Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.4M | 546 | 68.0% |
| Travel and Lodging | $421,057 | 1,104 | 19.8% |
| Consulting Fee | $131,944 | 59 | 6.2% |
| Honoraria | $77,088 | 27 | 3.6% |
| Food and Beverage | $50,093 | 1,221 | 2.4% |
| Education | $163.75 | 8 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $482,041 | 599 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $350,336 | 349 | $0 (2024) |
| Astellas Pharma US Inc | $287,984 | 392 | $0 (2024) |
| PFIZER INC. | $256,979 | 475 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $212,493 | 288 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $158,891 | 134 | $0 (2024) |
| TOLMAR Pharmaceuticals, Inc. | $88,677 | 86 | $0 (2022) |
| Myovant Sciences Inc. | $76,598 | 50 | $0 (2022) |
| Sumitomo Pharma America, Inc. | $45,121 | 42 | $0 (2024) |
| Amgen Inc. | $26,063 | 78 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $376,938 | 450 | Janssen Biotech, Inc. ($134,194) |
| 2023 | $402,007 | 482 | AstraZeneca Pharmaceuticals LP ($168,938) |
| 2022 | $355,718 | 426 | AstraZeneca Pharmaceuticals LP ($83,938) |
| 2021 | $232,638 | 252 | AstraZeneca Pharmaceuticals LP ($57,420) |
| 2020 | $153,267 | 247 | PFIZER INC. ($49,675) |
| 2019 | $302,678 | 501 | Janssen Biotech, Inc. ($105,437) |
| 2018 | $224,544 | 365 | Janssen Scientific Affairs, LLC ($131,709) |
| 2017 | $81,519 | 242 | Astellas Pharma US Inc ($19,003) |
All Payment Transactions
2,965 individual payment records from CMS Open Payments — Page 1 of 119
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $24.42 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Honoraria | Cash or cash equivalent | $3,850.00 | General |
| Category: Oncology | ||||||
| 12/18/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Travel and Lodging | Cash or cash equivalent | $969.28 | General |
| Category: Oncology | ||||||
| 12/18/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $104.68 | General |
| Category: Oncology | ||||||
| 12/18/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $10.89 | General |
| Category: Oncology | ||||||
| 12/13/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Travel and Lodging | In-kind items and services | $574.18 | General |
| Category: Oncology | ||||||
| 12/13/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Oncology | ||||||
| 12/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,350.00 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,125.00 | General |
| Category: Oncology | ||||||
| 11/25/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $29.17 | General |
| Category: ONCOLOGY | ||||||
| 11/22/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $170.53 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 11/21/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,550.00 | General |
| Category: Oncology | ||||||
| 11/21/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Travel and Lodging | Cash or cash equivalent | $973.97 | General |
| Category: Oncology | ||||||
| 11/21/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Travel and Lodging | Cash or cash equivalent | $584.89 | General |
| Category: Oncology | ||||||
| 11/21/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Travel and Lodging | Cash or cash equivalent | $224.10 | General |
| Category: Oncology | ||||||
| 11/21/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $124.13 | General |
| Category: Oncology | ||||||
| 11/21/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $8.26 | General |
| Category: Oncology | ||||||
| 11/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: UROLOGY | ||||||
| 11/18/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $19.91 | General |
| 11/16/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $52.71 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $189.59 | General |
| Category: General Therapies URO | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Travel and Lodging | Cash or cash equivalent | $156.01 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,525 | 6,320 | $495,835 | $169,976 |
| 2022 | 20 | 1,493 | 7,271 | $518,146 | $176,141 |
| 2021 | 24 | 1,495 | 7,330 | $503,807 | $167,096 |
| 2020 | 30 | 1,649 | 8,898 | $493,396 | $173,004 |
All Medicare Procedures & Services
98 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 13 | 2,880 | $120,960 | $52,560 | 43.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 394 | 540 | $172,800 | $48,188 | 27.9% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 35 | 228 | $76,608 | $30,601 | 39.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 48 | 195 | $31,005 | $9,094 | 29.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 118 | 134 | $30,418 | $8,763 | 28.8% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 36 | 36 | $7,524 | $2,815 | 37.4% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 11 | 11 | $5,698 | $2,193 | 38.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 28 | 28 | $5,796 | $1,791 | 30.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 22 | 22 | $6,226 | $1,695 | 27.2% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 42 | 68 | $5,462 | $1,602 | 29.3% |
| 51705 | Simple change of bladder tube | Office | 2023 | 13 | 18 | $4,374 | $1,381 | 31.6% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 62 | 67 | $4,020 | $1,381 | 34.3% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 13 | 13 | $4,329 | $1,366 | 31.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $5,908 | $1,300 | 22.0% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 12 | 24 | $3,744 | $1,020 | 27.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 361 | 453 | $2,265 | $996.60 | 44.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 47 | 92 | $3,220 | $975.92 | 30.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 119 | 138 | $828.00 | $811.44 | 98.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 50 | 56 | $1,456 | $438.84 | 30.1% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 13 | 13 | $845.00 | $332.15 | 39.3% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2023 | 13 | 13 | $819.00 | $318.76 | 38.9% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 12 | 1,200 | $1,200 | $145.27 | 12.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 25 | 33 | $198.00 | $112.53 | 56.8% |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | Office | 2023 | 24 | 44 | $132.00 | $93.88 | 71.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 18 | 4,020 | $164,880 | $68,617 | 41.6% |
About Dr. Scott Sellinger, MD
Dr. Scott Sellinger, MD is a Urology healthcare provider based in Tallahassee, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740243526.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Sellinger, MD has received a total of $2.1M in payments from pharmaceutical and medical device companies, with $376,938 received in 2024. These payments were reported across 2,965 transactions from 60 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.4M).
As a Medicare-enrolled provider, Sellinger has provided services to 6,162 Medicare beneficiaries, totaling 29,819 services with total Medicare billing of $686,217. Data is available for 4 years (2020–2023), covering 98 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Tallahassee, FL
- Active Since 04/11/2006
- Last Updated 03/09/2021
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1740243526
Products in Payments
- ERLEADA (Drug) $389,976
- LYNPARZA (Drug) $348,904
- XTANDI (Drug) $294,533
- Erleada (Drug) $238,289
- Nubeqa (Drug) $172,435
- Xtandi (Drug) $157,384
- ORGOVYX (Drug) $139,270
- ELIGARD (Drug) $105,314
- Xofigo (Drug) $29,900
- TALZENNA (Drug) $24,170
- PROVENGE (Drug) $21,549
- Prolia (Biological) $20,878
- LYNPARZA (Biological) $14,348
- NOCDURNA (Drug) $12,227
- Androgel (Drug) $12,064
- DARZALEX (Biological) $10,878
- FIRMAGON (Drug) $9,014
- Non-Covered (Drug) $8,084
- PYLARIFY (Drug) $7,805
- CAMCEVI (Drug) $6,005
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Tallahassee
Dr. Jean-Paul Tran, Md, MD
Urology — Payments: $23,918
Dr. Robert Bradford, Md, MD
Urology — Payments: $17,195
Dr. Joseph Camps, Md, MD
Urology — Payments: $9,784
Jamey Sarvis
Urology — Payments: $9,765
Dr. Christopher Murphy, D.o, D.O
Urology — Payments: $9,130
Dr. James Renehan, Md, MD
Urology — Payments: $8,893